Since 2014, specialising in Mergers & Acquisitions
DOWNLOAD PDF Every few decades, the pharmaceutical industry discovers a molecule that completely changes the way we live. Insulin did it in the 1920s, penicillin followed in the 1940s, and statins in the 1980s. It’s been a long time coming, but GLP-1-based therapies now appear poised to join that lineage. In a sense, the comparison … Continue reading How a Pre-Revenue Anti-Obesity Biotech Became Pharma’s Most Coveted Target: Inside the $10bn Bidding War for Metsera
DOWNLOAD PDF Introduction Although improvements in medical technology have accelerated at breakneck speed over the past decades, drug discovery has been seemingly inverting this trend. Since the 1950s, the chances of a drug successfully passing clinical trials and becoming a new molecular entity (NME) have been steadily declining. This was the observation that researchers at … Continue reading On Recursion–Exscientia and The Long Game of Reinventing Drug Discovery
Bocconi Students M&A Circle 
You must be logged in to post a comment.